Skip to main content

Table 1 Chemotherapy regimens for NSCLC

From: A multicenter randomized controlled open-label trial to assess the efficacy of compound kushen injection in combination with single-agent chemotherapy in treatment of elderly patients with advanced non-small cell lung cancer: study protocol for a randomized controlled trial

Chemotherapy regimen

Dosage (mg/m2)

Medication time

TP:

  

Paclitaxel

135–175

D1

Cis-platinum

75

D1

Carboplatin

AUC = 5–6

D1

GP:

  

Gemcitabine

1,250

D1, D8

Cis-platinum

75

D1

Carboplatin

AUC = 5–6

D1

DP:

  

Docetaxel

75

D1

Cis-platinum

75

D1

Carboplatin

AUC = 5–6

D1

  1. Notes: The dosage of chemotherapy regimens are only for reference, and specific implementation will take clinical application as a standard